IDEX Biometrics ASA
IDBA · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1,394 | $1,298 | $1,244 | $1,242 |
| - Cash | $1 | $2 | $3 | $11 |
| + Debt | $3 | $4 | $8 | $11 |
| Enterprise Value | $1,395 | $1,300 | $1,249 | $1,241 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | -84.1% | 8.4% | -30.2% | – |
| Gross Profit | -$1 | $0 | -$3 | -$4 |
| % Margin | -2,423.3% | 39.5% | -912.9% | -731.2% |
| EBITDA | $2 | -$5 | -$4 | -$5 |
| % Margin | 2,638.3% | -1,266.2% | -1,188.2% | -914.9% |
| Net Income | $1 | -$7 | -$5 | -$5 |
| % Margin | 2,266.7% | -1,732.2% | -1,457% | -1,031% |
| EPS Diluted | 0.046 | -0.023 | -0.018 | -0.019 |
| % Growth | 305.7% | -23.9% | 2.9% | – |
| Operating Cash Flow | -$2 | -$5 | -$7 | -$4 |
| Capital Expenditures | $2 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$5 | -$7 | -$4 |